Burning Rock Biotech (BNR) Inventory Average: 2021-2025
Historic Inventory Average for Burning Rock Biotech (BNR) over the last 4 years, with Mar 2025 value amounting to $37.0 million.
- Burning Rock Biotech's Inventory Average rose 300.82% to $37.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $37.0 million, marking a year-over-year increase of 300.82%. This contributed to the annual value of $9.2 million for FY2024, which is 36.05% down from last year.
- Per Burning Rock Biotech's latest filing, its Inventory Average stood at $37.0 million for Q1 2025, which was up 310.04% from $9.0 million recorded in Q4 2024.
- Burning Rock Biotech's Inventory Average's 5-year high stood at $107.8 million during Q2 2023, with a 5-year trough of $8.9 million in Q2 2024.
- Moreover, its 3-year median value for Inventory Average was $37.0 million (2025), whereas its average is $43.3 million.
- In the last 5 years, Burning Rock Biotech's Inventory Average surged by 440.29% in 2023 and then tumbled by 91.74% in 2024.
- Burning Rock Biotech's Inventory Average (Quarterly) stood at $18.7 million in 2021, then surged by 353.89% to $84.7 million in 2022, then crashed by 43.16% to $48.1 million in 2023, then tumbled by 81.25% to $9.0 million in 2024, then soared by 300.82% to $37.0 million in 2025.
- Its Inventory Average was $37.0 million in Q1 2025, compared to $9.0 million in Q4 2024 and $9.3 million in Q3 2024.